A randomized single blind placebo-controlled 12 weeks study to know the efficacy of Bacopa Monnieri (Brahmi) mother tincture in managing Examination Funk in 18 - 25 years age group students by using examination anxiety scale
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 146
- 试验地点
- 1
- 主要终点
- Significant reduction in anxiety and improvement in cognitive function in the experimental group compared to the control group
研究概览
简要总结
The purpose of this study is to evaluate the efficacy of Brahmi supplementation in alleviating the symptoms of examination funk among university students. Specifically, the study will assess whether Brahmi can reduce anxiety, enhance cognitive function, and improve physical symptoms like fatigue and sleep disturbances, thereby improving overall exam performance. Brahmi, also known as Bacopa monnieri, is a well-known medicinal herb used extensively in Ayurveda and Homoeopathy as a nervine tonic. It is considered a nootropic, enhancing cognitive functions such as memory, concentration, and learning ability. In homoeopathy, it is primarily prescribed for neurological disorders, mental fatigue, anxiety, and stress-induced ailments. Examination anxiety is a significant issue among adolescents, and young adults affecting their mental health and academic performance. While Brahmi (Bacopa monnieri) is traditionally recognized for its calming and cognitive-enhancing effects, no prior research has specifically evaluated its efficacy in managing examination funk within the context of Homoeopathy. This study aims to address this gap by conducting a randomized placebo-controlled trial to assess the effectiveness of Brahmi mother tincture in reducing examination anxiety. Using a culturally relevant and standardized Examination Anxiety Scale for Adolescents, this research represents a novel contribution to Homoeopathy and adolescent mental health management.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 25.00 Year(s)(—)
- 性别
- All
入选标准
- •Undergraduate students aged 18-25 years.
- •Experiencing symptoms of examination funk including anxiety cognitive impairment and physical discomfort.
排除标准
- •Students with underlying medical conditions Known cases of psychiatric disorders Generalized Anxiety Disorder as per the Hamilton Anxiety scale those taking other supplements or medications that may interfere with the study.
结局指标
主要结局
Significant reduction in anxiety and improvement in cognitive function in the experimental group compared to the control group
时间窗: outcome of study will be assessed by using EAS a pre and post treatment scores of EAS will be compared every three months for a total period of 9 months in the students with examination funk in students of age 18 to 25 years
次要结局
未报告次要终点
研究者
Dr Diksha Goyal
HOMOEOPATHY UNIVERSITY
